Insider Transactions Reported by 18 Insiders of Nautilus Biotechnology, Inc.

Symbol
NAUT on Nasdaq
Location
Seattle, WA

Insiders trading volume in the past year

Nautilus Biotechnology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sujal M. Patel CEO, President, and Secretary, Director, 10%+ Owner $42,376,101 +$277,730 +0.66% 04 Mar 2026
AH Equity Partners Bio II, L.L.C. 10%+ Owner $35,833,921 09 Jun 2021
Parag Mallick Chief Scientist, Director, 10%+ Owner $14,995,014 +$9,885 +0.07% 02 Mar 2026
Anna Mowry CFO and Treasurer $63,569 +$11,489 +22% 02 Mar 2026
Matthew B. Murphy General Counsel $48,664 +$12,858 +36% 02 Mar 2026
Kentaro Suzuki Chief Marketing Officer $5,960 +$5,960 02 Mar 2026
Mary E. Godwin Senior VP, Operations $0 23 Sep 2024
FARZAD NAZEM Director 23 Jun 2025
Melissa B. Epperly Director 23 Jun 2025
Karen Akinsanya Director 23 Jun 2025
Gwen E. Weld Chief People Officer 02 Mar 2026
Matthew S. McIlwain Director 23 Jun 2025
Subramanian Sankar Senior VP, Product Development 02 Mar 2026
Nicholas A. Nelson CBO & Senior VP, Bus. Dev. 03 Mar 2025
Vijay Satyanand Pande Director 14 Jun 2024
PERCEPTIVE ADVISORS LLC Director, 10%+ Owner 14 Jun 2024
MICHAEL SETH ALTMAN Director 14 Jun 2024
Matthew L. Posard Director 23 Jun 2025

Recent Insider Transactions by Companies or Individuals for Nautilus Biotechnology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.